Short Interest in Ascentage Pharma Group International (OTCMKTS:ASPHF) Increases By 29.6%

Ascentage Pharma Group International (OTCMKTS:ASPHF) was the recipient of a significant growth in short interest in December. As of December 31st, there was short interest totaling 161,400 shares, a growth of 29.6% from the December 15th total of 124,509 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

Ascentage Pharma Group International Stock Performance

Ascentage Pharma Group International stock opened at $8.48 on Friday. Ascentage Pharma Group International has a 52-week low of $7.50 and a 52-week high of $10.65. The company’s 50 day moving average is $8.62 and its two-hundred day moving average is $8.44.

About Ascentage Pharma Group International

Ascentage Pharma Group International (OTCMKTS:ASPHF) is a clinical-stage biopharmaceutical company headquartered in Beijing, China, with a strategic presence in the United States. The company focuses on the discovery and development of targeted small-molecule therapies that modulate programmed cell death, leveraging a deep understanding of the Bcl-2 family of proteins.

Ascentage’s core activities center on the research and development of apoptosis regulators, including both Bcl-2 selective and dual Bcl-2/Bcl-xL inhibitors.